AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
Recruiting now · Phase 2
Conditions studied: Refractory Rheumatoid Arthritis (RA), Idiopathic Inflammatory Myopathies (IIMs), Systemic Sclerosis (SSc), Rheumatoid Arthritis (RA, IIM, Myositis, Scleroderma, Sjogren Syndrome, Sjogrens Disease
In brief
A Basket Trial of Refractory Rheumatoid Arthritis (RA), Sjögren's Disease (SjD), Idiopathic Inflammatory Myopathies (IIMs) and Systemic Sclerosis (SSc) subjects to evaluate the safety and efficacy of AlloNK, a non-genetically modified allogeneic NK cell, in combination with rituximab.
Key facts
- Study ID
- NCT06991114
- Run by
- Artiva Biotherapeutics, Inc.
- People needed
- 90
- Starts
- 2025-07-09
- Expected to finish
- 2029-01-01
- Last updated by the study team
- 2026-07-31
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Artiva Investigational Site Phoenix — Phoenix, Arizona, United States (enrolling)
- Artiva Investigational Site Tucson — Tucson, Arizona, United States (enrolling)
- Artiva Investigational Site Chula Vista — Chula Vista, California, United States (enrolling)
- Artiva Investigational Site Covina — Covina, California, United States (enrolling)
- Artiva Investigational Site Los Alamitos — Los Alamitos, California, United States (enrolling)
- Artiva Investigational Site Los Angeles — Los Angeles, California, United States (enrolling)
- Artiva Investigational Site Santa Ana — Santa Ana, California, United States (enrolling)
- Artiva Investigational Site Tustin — Tustin, California, United States (enrolling)
- Artiva Investigational Site Jupiter — Jupiter, Florida, United States (enrolling)
- Artiva Investigational Site Miami — Miami, Florida, United States (enrolling)
- Artiva Investigational Site Plantation — Plantation, Florida, United States (enrolling)
- Artiva Investigational Site Gainesville — Gainesville, Georgia, United States (enrolling)
- Artiva Investigational Site Norcross — Norcross, Georgia, United States (enrolling)
- Artiva Investigational Site Willowbrook — Willowbrook, Illinois, United States (enrolling)
- Artiva Investigational Site Iowa — Iowa City, Iowa, United States (enrolling)
- Artiva Investigational Site Iowa Great Falls — Great Falls, Montana, United States (enrolling)
- Artiva Investigational Site Charlotte — Charlotte, North Carolina, United States (enrolling)
- Artiva Investigational Site Charlotte — Charlotte, North Carolina, United States (enrolling)
- Artiva Investigational Site Statesville — Statesville, North Carolina, United States (enrolling)
- Artiva Investigational Site Charleston — Charleston, South Carolina, United States (enrolling)
- Artiva Investigational Site Hixson — Hixson, Tennessee, United States (enrolling)
- Artiva Investigational Site Jackson — Jackson, Tennessee, United States (enrolling)
- Artiva Investigational Site Arlington — Arlington, Texas, United States (enrolling)
- Artiva Investigational Site Bellaire — Bellaire, Texas, United States (enrolling)
- Artiva Investigational Site Tuscaloosa — Tuscaloosa, Alabama, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.